Search | IOVS | ARVO Journals

iovs

Issues
Topics
For Authors
About
- Editorial Board

Journals Home

MANAGE ALERTS

Access Provided By:
MIT Libraries

Forgot password?

Create an Account

To View More...

Purchase this article with an account.

or

Subscribe Now

Issues
Topics
For Authors
About
- Editorial Board

Narrow View

NARROW

Content Type

Meeting Abstract (11)
Journal Articles (1)

Journal

Investigative Ophthalmology & Visual Science (12)

Article Type

ARVO Annual Meeting Abstract (11)
Cornea (1)

Topics

Cornea (1)
External Eye Disease (1)
Eye Anatomy and Disorders (1)

Tags

dry eye syndromes (1)
eye (1)
phase 2 clinical trials (1)
placebos (1)
rna (1)
rna, small interfering (1)
safety (1)

Specify Date Range

From: To: Apply

Showing 1 – 12 of 12

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2023

Stability study of a preservative-free formulation of SYL1801, a siRNA indicated for neovascular AMD, in Novelia® multidose eye dropper

Veronica Ruz; Beatriz Vargas; Lola Company; Anne-Marie Bleau; Ana Isabel Jimenez

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):736.

ARVO Annual Meeting Abstract June 2023

Long-term safety studies of tivanisiran for the treatment of Dry Eye Disease (DED)

Anne-Marie Bleau; Veronica Ruz; Beatriz Vargas; Ana Isabel Jimenez

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):3954.

ARVO Annual Meeting Abstract June 2022

Phase I of SYL1801, a new siRNA delivered in eye drops for age-related macular degeneration

Ana Isabel Jimenez; Veronica Ruz; Beatriz Vargas; Anne Marie Bleau

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):337 – F0168.

ARVO Annual Meeting Abstract June 2020

Tivanisiran as a new treatment for Dry Eye in patients with Sjögren Syndrome

Victoria Gonzalez; Veronica Ruz; Anne Marie Bleau; Beatriz Vargas; Ana Isabel Jimenez

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):102.

ARVO Annual Meeting Abstract July 2019

Clinical Results of tivanisiran, a siRNA for the treatment of dry eye disease

Veronica Ruz; Victoria Gonzalez; Anne-Marie Bleau; Beatriz Vargas; Ana Isabel Jimenez

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):6738.

ARVO Annual Meeting Abstract July 2018

Development of a RNAi therapeutic for the treatment of allergic conjunctivitis

Victoria Gonzalez; Covadonga Paneda; Tamara Martinez; Amor Guerra; Susana Monteiro; Beatriz Vargas; Anne Marie Bleau; Veronica Ruz; Ana Isabel Jimenez

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):5567.

ARVO Annual Meeting Abstract July 2018

Tivanisiran, a new treatment for Dry Eye Disease, that improved signs and symptoms in clinical trials

Ana Isabel Jimenez; Veronica Ruz; Victoria Gonzalez; Covadonga Paneda; Tamara Martinez; Beatriz Vargas; Anne Marie Bleau

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):925.

ARVO Annual Meeting Abstract June 2017

Clinical and preclinical study correlation for SYL1001, a new treatment for dry eye disease

Victoria Gonzalez; Veronica Ruz; Covadonga Pañeda; Anne-Marie Bleau; Beatriz Vargas; Ana Isabel Jimenez

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):2670.

Cornea November 2016

Safety and Efficacy Clinical Trials for SYL1001, a Novel Short Interfering RNA for the Treatment of Dry Eye Disease

PDF

José Manuel Benitez-Del-Castillo; Javier Moreno-Montañés; Ignacio Jiménez-Alfaro; Francisco José Muñoz-Negrete; Krista Turman; Kadi Palumaa; Belén Sádaba; María Victoria González; Verónica Ruz; Beatriz Vargas; Covadonga Pañeda; Tamara Martínez; Anne-Marie Bleau; Ana Isabel Jimenez
TAGS: dry eye syndromes, placebos, rna, rna, small interfering, safety, phase 2 clinical trials, eye
Invest. Ophthalmol. Vis. Sci.. 2016; 57(14):6447-6454. https://doi.org/10.1167/iovs.16-20303

Includes: Supplemental Content

ARVO Annual Meeting Abstract September 2016

The Effect of Preserved Anti-glaucoma Eye-drops on Goblet Cells and the Expression of Pro-inflammatory Markers.

Javier Moreno-Montanes; Gonzalo Carracedo; Elena Carnero; Anne-Marie Bleau; Begoña Fonseca; Alejandro Martínez-Águila; Jesus J Pintor; Adriano Guarnieri

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):3504.

ARVO Annual Meeting Abstract June 2015

Irreversible Effect of Topical Antiglaucomatous Therapy on the Meibomian Glands.

Anne-Marie Bleau; Adriano Guarnieri; Alfonso Luis Sabater; Alvaro Velazquez Villoria; Javier Moreno-Montanes

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):5688.

ARVO Annual Meeting Abstract June 2015

Quantitative measurement of conjunctival hyperemia and tear film properties in glaucoma patients using the Keratograph 5M.

Alfonso Luis Sabater; Anne-Marie Bleau; Adriano Guarnieri; Vanesa Antón; Gema Rebolleda; Javier Moreno-Montanes

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):3053.

« Previous

Advertisement

Follow @ARVOiovs

IOVS Home
Issues
Topics
For Authors
About
- Editorial Board

Online ISSN: 1552-5783

Investigative Ophthalmology & Visual Science
Journal of Vision
Translational Vision Science & Technology

JOURNALS HOME
TOPICS
ABOUT ARVO JOURNALS

Copyright © 2025 Association for Research in Vision and Ophthalmology.

Access Provided By:
MIT Libraries

Forgot password?

To View More...

Purchase this article with an account.

Create an Account

or

Subscribe Now

×

×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×

This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.Accept